Contents list

Literature Information

Publication Date
DOI 10.1039/C7SE90030A
Impact Factor 6.367
Authors


View Original

Abstract

The first page of this article is displayed as the abstract.

Related Literature

The interface between HOPG and 1-butyl-3-methyl-imidazolium hexafluorophosphate

C. Müller, K. Németh, S. Vesztergom, T. Pajkossy

2015-11-27 Paper

DOI: 10.1039/C5CP05406K

The R- and S-diastereoisomeric effects on the guanidinohydantoin-induced mutations in DNA

N. R. Jena, Vivek Gaur, P. C. Mishra

2015-06-15 Paper

DOI: 10.1039/C5CP02636A

An adaptive finite-element method for large-scale ab initio molecular dynamics simulations

Eiji Tsuchida, Yoong-Kee Choe, Takahiro Ohkubo

2015-04-20 Paper

DOI: 10.1039/C5CP00320B

Towards the first theoretical scale of the trans effect in octahedral complexes

Vincent Tognetti, Laurent Joubert, Henry Chermette, Dominique Luneau, Christophe Morell

2015-11-18 Paper

DOI: 10.1039/C5CP04982B

STM investigation of structural isomers: alkyl chain position induced self-assembly at the liquid/solid interface

Yi Hu, Kai Miao, Bao Zha, Li Xu, Xinrui Miao, Wenli Deng

2015-11-19 Paper

DOI: 10.1039/C5CP05795G

Sign change of magnetoresistance in Gd-doped amorphous carbon granular films

Shihao Ding, Chao Jin, Ziwei Fan, Peng Li, Haili Bai

2015-10-26 Paper

DOI: 10.1039/C5CP05070G

Direct determination of ionic transference numbers in ionic liquids by electrophoretic NMR

Martin Gouverneur, Jakob Kopp, Leo van Wüllen, Monika Schönhoff

2015-10-27 Paper

DOI: 10.1039/C5CP05753A

High rectification in organic diodes based on liquid crystalline phthalocyanines

Petru Apostol, Juliana Eccher, Marta Elisa Rosso Dotto, Cassiano Batesttin Costa, Thiago Cazati, Elizabeth A. Hillard, Harald Bock, Ivan H. Bechtold

2015-11-11 Paper

DOI: 10.1039/C5CP05582B

Inside back cover

Cover

DOI: 10.1039/C5CP90222C

You might also like

Compound Q&A

What are the main uses of (3alpha,5alpha)-3-Hydroxypregnane-11,20-dione (CAS: 23930-19-0)?

(3alpha,5alpha)-3-Hydroxypregnane-11,20-dione is primarily used in the pharmaceu...

23930-19-0(3alpha,5alpha)-3-Hy...
Compound Q&A

What is the market or research trend for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4)?

The market for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4) is ...

546141-56-44-Amino-6-chloro-2-p...
Compound Q&A

Are there alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in synthesis?

Alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in ...

24472-88-6(2-Benzoylethyl)trim...
Compound Q&A

Is N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) safe?

N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) is generally safe...

393-12-4N-[4-Nitro-3-(triflu...
Compound Q&A

Are there alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-14-5) in synthesis?

There are alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-...

4605-14-5N,N'-Bis(3-aminoprop...
Compound Q&A

What precautions should be taken when handling Aluminium trihexadecanoate (CAS: 555-35-1)?

When handling Aluminium trihexadecanoate, it is important to use appropriate per...

555-35-1Aluminium trihexadec...
Compound Q&A

What is (1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid (CAS: 52188-11-1)?

(1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid is a chemical compound ...

52188-11-1(1,1-Dioxido-3-oxo-1...
Compound Q&A

Are there alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) in synthesis?

Several alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) can be used in...

3123-97-55,5-dimethyloxolan-2...
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.